PROTECS and Fraunhofer Advance Vaccine Manufacturing in Newark, Delaware

The Fraunhofer USA Center for Molecular Biotechnology, a not-for-profit, 501 (c3) research organization, announced today that it has received a $60,000 gift from PROTECS, Inc., to complete its new, state of-the-art vaccine manufacturing plant in Newark, Delaware. According to Dr. Vidadi Yusibov, Executive Director of the Center, “The donation by PROTECS is important because it will aid the […]

Read More